Oppenheimer Downgrades Soleno Therapeutics Inc. (SLNO) to Perform
Oppenheimer analyst Leland Gershell downgraded Soleno Therapeutics Inc. (NASDAQ: SLNO) from Outperform to Perform.The analyst commented, "We caught up with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)